09.12.2014 • NewsSigma-AldrichMercktransaction

Sigma-Aldrich Shareholders Approve Takeover by Merck

At a special meeting held at the Sigma-Aldrich Life Science and Technology Center in St. Louis, Missouri, USA, 78% of the company's shareholders approved the planned takeover by Germany's Merck KGaA for $17 billion in cash. The Sigma-Aldrich board of directors had previously unanimously approved the deal.

Under the agreement announced on Sept. 22, 2014, Merck will acquire all of the outstanding Sigma-Aldrich shares for $140 per share in cash. A Merck shareholder vote is not required.

The Darmstadt-based chemical and pharmaceutical producer said it continues to expect to close the transaction, which is still subject to regulatory approvals, in mid- 2015. It said it is "is working closely with authorities to ensure a seamless transaction."

Merck said the acquisition is a key element in its "Fit for 2018" transformation and growth program aimed at strengthening its healthcare, life science and performance materials platforms.

The merger of Sigma-Aldrich and Merck's laboratory chemicals offshoot Merck Millipore would be able to offer the Laboratory & Academia sector a complementary range of products across laboratory chemicals, biologics and reagents.

In pharma and biopharma production, Merck said Sigma-Aldrich would complement Merck Millipore's existing products and capabilities with additions along the entire value chain of drug production and validation.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.